Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ying Chen has a total of 211 co-authors. Here are the top co-authors by number of shared publications:

  • Hong Li

    Department of Obstetrics, 2 Department of Neonatology, 3 Department of Gynecology, 4 Center for Reproduction and Genetics, Nanjing Medical University Affiliated Suzhou Hospital, Suzhou 215002, China

    13 shared publications
  • Jun Mao

    Central Lab, Suzhou Hospital Affiliated to Nanjing Medical University, Suzhou, Jiangsu, China

    10 shared publications
  • Min-Juan Liu

    Center for Reproduction and Genetics, Nanjing Medical University Affiliated Suzhou Hospital, Suzhou 215002, China

    6 shared publications
  • Ailing Chen

    Translational Medicine Laboratory, Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China

    5 shared publications
  • Hong-Bo Cheng

    5 shared publications
  • Kwong Wai Choy

    Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China

    5 shared publications

Latest Publications

  • FTO/m6A Regulate Prenatal Nicotine-Induced eNOS Uncoupling and BP Susceptibility

    by Bailin Liu, Erhuan He, Na Li, Yang Ye, Yong Li, Wansu Yu, Taiming Liu, Xuesi M Shao, Lubo Zhang, Ying Chen, et al.

    BACKGROUND: Prenatal nicotine exposure from maternal smoking or e-cigarette use increases cardiovascular risk in offspring, but the underlying mechanisms remain unclear. We tested whether FTO (fat mass and obesity-associated protein)-mediated N6-methyladenosine RNA demethylation drives eNOS (endothelial nitric oxide [NO] synthase) uncoupling and programmed hypertensive susceptibility following prenatal nicotine exposure. METHODS: Using a clinically relevant rat model of chronic intermittent nicotine aerosol exposure or saline aerosol control during gestational days 4 to 21, experiments were performed in adult offspring and human umbilical vein endothelial cells. RESULTS: Prenatal chronic intermittent nicotine aerosol programmed a male-specific increase in hypertensive susceptibility without altering baseline blood pressure. Adult male offspring exhibited enhanced pressor responses to vasoconstrictor stimuli, impaired endothelium-dependent vasodilation, paradoxical eNOS overexpression, reduced NO bioavailability, increased superoxide and hydrogen peroxide production, impaired eNOS dimerization, and decreased tetrahydrobiopterin levels associated with reduced GTPCH1 (GTP cyclohydrolase-1) expression, consistent with eNOS uncoupling. Mechanistically, prenatal chronic intermittent nicotine aerosol increased vascular FTO expression and induced site-specific N6-methyladenosine hypomethylation of eNOS mRNA. Pharmacological inhibition of FTO with FB23-2 restored eNOS and GTPCH1 expression, improved eNOS dimerization, and normalized NO production in mesenteric arteries. In human umbilical vein endothelial cells, nicotine exposure recapitulated FTO-dependent eNOS uncoupling, which was reversed by FB23-2 or siRNA-mediated FTO knockdown. CONCLUSIONS: Prenatal nicotine exposure disrupts endothelial redox homeostasis through FTO-dependent N6-methyladenosine RNA demethylation, leading to tetrahydrobiopterin deficiency, eNOS uncoupling, and vascular dysfunction in male offspring. The FTO—tetrahydrobiopterin—eNOS pathway represents a novel epitranscriptomic mechanism underlying programmed hypertensive susceptibility and a potential therapeutic target for offspring exposed to nicotine during development.

  • Liquiritigenin Restores Declined Oocyte Quality and Improves Embryo Development in Aged Mice

    by Yelan Cai, Jiawei Ma, Haifeng Xu, Huamei Jian, Wenyi Gao, Man Wu, Bailin Liu, Ying Chen

    Ovarian aging leads to a decline in oocyte quality and reduced reproductive potential, which is one of the main challenges faced by assisted reproductive technology (ART). Oxidative stress (OS) is a major contributor to this decline. In this study, we investigated the protective effects of natural flavonoid compound liquiritigenin (LQ) on oocyte maturation and embryo development in aged mice. The results showed that 20 μM LQ significantly improved the maturation rate of aged oocytes, restored spindle morphology, and enhanced fertilization and two-cell embryo development rates. Mechanism studies have found that LQ reduces the levels of reactive oxygen species (ROS) in oocytes and restores mitochondrial function, including distribution patterns and membrane potential. Additionally, LQ upregulated the protein expression of Sirtuin 1 (SIRT1) and nuclear factor E2-related factor 2 (NRF2) in the ovaries and oocytes of aging mice, as well as in the human ovarian granulosa tumor cell line (KGN). Although its mRNA level showed minimal change, it suggested that it might play a role through post-translational regulation. These results suggest that LQ protects aged oocytes from oxidative stress by activating the SIRT1/NRF2 signaling pathway, highlighting its potential as a natural antioxidant for alleviating ovarian aging and improving oocyte quality. Graphical Abstract


  • 元宇宙在老年人群认知衰退干预中的应用场景研究

    by Defu Zhou, Yi Jin, Ying Chen

    我国将迎来老龄化高峰,老龄群体对智慧型医疗保健的服务需求骤增。元宇宙作为新型互联网社会交流空间,显示出无限应用潜力。本文聚焦医学元宇宙在老年人群认知衰退干预中的应用问题,回顾了认知评估和诊疗中的问题,介绍了构建医学元宇宙所需数据,分析表明老龄用户可通过该技术进行自助式监测、体验沉浸式自我疗愈和保健,提出医学元宇宙在认知衰退的预测和诊断、预防和康复、辅助患者生活等方面有显著优势,并指出了应用的风险点。医学元宇宙技术解决了老龄用户非面对面社会交流问题,将有助于老龄群体的社会医疗体系和服务模式的重构。

  • Open Access

    High carrier frequency of pathogenic PATL2 gene mutations predicted in population: a bioinformatics-based approach

    by Hao Zhou, Ye-Lan Cai, Qing Luo, Lian Zou, Yong-Xiang Yin, Ying Chen, Fang Xiong

    Topoisomerase II homologue 2 (PATL2) has been confirmed to be a key gene that contributes to oocyte maturation. However, the allele distribution and carrier frequency of these mutations remain uncharacterized. So a bioinformatics subcategory analysis of PATL2 mutations from outcome data and Single Nucleotide Polymorphism (SNP) databases was conducted. Altogether, the causative PATL2 mutation number detected in patients with oocyte maturation defects in the clinical studies and pathogenic PATL2 mutation sites predicted by software based on the database was approximately 53. The estimated carrier frequency of pathogenic mutation sites was at least 1.14‰ based on the gnomAD and ExAC database, which was approximately 1/877. The highest frequency of mutations detected in the independent patients was c.223-14_223-2del13. The carrier frequency of this mutation in the population was 0.25‰, which may be a potential threat to fertility. Estimated allele and carrier frequency are relatively higher than those predicted previously based on clinical ascertainment. A review of PATL2 mutation lineage identified in 34 patients showed that 53.81%, 9.22% and 14.72% of the oocytes with PATL2 mutations were arrested at the germinal vesicle (GV) stage, metaphase I (MI) stage and first polar body stage, respectively. Oocytes that could develop to the first polar body stage were extremely rare to fertilise, and their ultimate fate was early embryonic arrest. Phenotypic variability is related to the function of the regions and degree of loss of function of PATL2 protein. A 3D protein structure changes predicted by online tools, AlphaFold, showed aberrations at the mutation sites, which may explain partially the function loss. When the mutated and wild-type proteins are not in the same amino acid category, the protein structure will be considerably unstable. The integration of additional mutation sites with phenotypes is helpful in drawing a complete picture of the disease. Bioinformatics analysis of PATL2 mutations will help reveal molecular epidemiological characteristics and provide an important reference for new mutation assessment, genetic counselling and drug research.


  • Open Access

    Supplementary Table S3 from Antisense RNAs Influence Promoter Usage of Their Counterpart Sense Genes in Cancer

    by Fernando Bellido Molias, Andre Sim, Ka Wai Leong, Omer An, Yangyang Song, Vanessa Hui En Ng, Max Wei Jie Lim, Chen Ying, Jasmin Xin Jia Teo, Jonathan Göke, et al.

  • Open Access

    The paradigm and future value of the metaverse for the intervention of cognitive decline

    by Hao Zhou, Jian-Yi Gao, Ying Chen

    Cognitive decline is a gradual neurodegenerative process that is affected by genetic and environmental factors. The doctor-patient relationship in the healthcare for cognitive decline is in a “shallow” medical world. With the development of data science, virtual reality, artificial intelligence, and digital twin, the introduction of the concept of the metaverse in medicine has brought alternative and complementary strategies in the intervention of cognitive decline. This article technically analyzes the application scenarios and paradigms of the metaverse in medicine in the field of mental health, such as hospital management, diagnosis, prediction, prevention, rehabilitation, progression delay, assisting life, companionship, and supervision. The metaverse in medicine has made primary progress in education, immersive consultation, dental disease, and Parkinson's disease, bringing revolutionary prospects for non-pharmacological complementary treatment of cognitive decline and other mental problems. In particular, with the demand for non-face-to-face communication generated by the global COVID-19 epidemic, the needs for uncontactable healthcare service for the elderly have increased. The paradigm of self-monitoring, self-healing, and healthcare experienced by the elderly through the metaverse in medicine, especially from meta-platform, meta-community, and meta-hospital, will be generated, which will reconstruct the service modes for the elderly people. The future map of the metaverse in medicine is huge, which depends on the co-construction of community partners.


  • Open Access

    Recent Advances of MicroRNAs, Long Non-coding RNAs, and Circular RNAs in Preeclampsia

    by Ailing Chen, Renqiang Yu, Shiwen Jiang, Yankai Xia, Ying Chen

    Preeclampsia is a clinical syndrome characterized by multiple-organ dysfunction, such as maternal hypertension and proteinuria, after 20 weeks of gestation. It is a common cause of fetal growth restriction, fetal malformation, and maternal death. At present, termination of pregnancy is the only way to prevent the development of the disease. Non-coding RNAs, including microRNAs, long non-coding RNAs, and circular RNAs, are involved in important pathological and physiological functions in life cycle activities including ontogeny, reproduction, apoptosis, and cell reprogramming, and are closely associated with human diseases. Accumulating evidence suggests that non-coding RNAs are involved in the pathogenesis of preeclampsia through regulation of various physiological functions. In this review, we discuss the current evidence of the pathogenesis of preeclampsia, introduce the types and biological functions of non-coding RNA, and summarize the roles of non-coding RNA in the pathophysiological development of preeclampsia from the perspectives of oxidative stress, hypoxia, angiogenesis, decidualization, trophoblast invasion and proliferation, immune regulation, and inflammation. Finally, we briefly discuss the potential clinical application and future prospects of non-coding RNA as a biomarker for the diagnosis of preeclampsia.


  • Open Access

    Progesterone activates the cyclic AMP-protein kinase A signalling pathway by upregulating ABHD2 in fertile men

    by Feng Jiang, Yong Zhu, Ying Chen, Xiaofeng Tang, Liu Liu, Guowu Chen, Yulin Liu, Xiaoxi Sun

    This was a prospective study to investigate whether progesterone affects sperm activity by regulating the cyclic AMP-protein kinase A (cAMP-PKA) signalling pathway via α/β hydrolase domain-containing protein 2 (ABHD2). Spermatozoa were collected from healthy and infertile men (with oligoasthenospermia or abnormal acrosome; n = 30/group). The expression of and mutations in ABHD2 were detected by quantitative PCR, western blot, and gene sequencing. The expression of ABHD2 in the presence of progesterone was detected in all groups, and cAMP and PKA levels were detected by ELISA in fertile men after treatment with ABHD2 antibody and PKA inhibitor H-89, respectively. Expression of ABHD2 mRNA and protein were reduced in spermatozoa from infertile compared with fertile men. Four gene mutation sites were detected in spermatozoa from the infertile groups. Progesterone increased mRNA and protein levels of ABHD2 in healthy spermatozoa but not in spermatozoa from infertile men. The levels of cAMP and PKA were increased by progesterone in healthy spermatozoa, and the progesterone-increased cAMP and PKA were decreased by ABHD2 antibody and H-89, respectively. Progesterone regulates the ABHD2-mediated cAMP-PKA signalling pathway in healthy spermatozoa, which provides a new target for clinical diagnosis and treatment of infertility.


  • Metabolomics study and meta-analysis on the association between maternal pesticide exposome and birth outcomes

    by Xu Yang, Mingzhi Zhang, Ting Lu, Shiyao Chen, Xian Sun, Yusheng Guan, Yiyun Zhang, Ting Zhang, Rongli Sun, Bo Hang, et al.